As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Augnito’s AI comprehends all English accents with 99% accuracy
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Convergent action on AMR identified as an important area of intervention
Subscribe To Our Newsletter & Stay Updated
